| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.69 | 0.001 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.54 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.41 | 0.05 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.38 | 0.07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.34 | 3e-17 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.34 | 4e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.33 | 8e-09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.31 | 5e-08 |